DiaMonTech submits to FDA pre-submission application for non-invasive blood glucose meter D-Base

Berlin, 9 September 2020

With the submission of the pre-submissionapplication to the US Food and Drug Administration (FDA), the company has initiated the approval process of its product D-Base as a medical device in the US.

D-Base uses the innovative DiaMonTech technology for non-invasive, precise,and painless measurement of blood glucose levels and it is optimized for use in professional environments such as diabetes centers.

For diabetes patients and prediabetics, DiaMonTech is developing the smaller D-Pocket, which builds on the same laser technology.

In the next step of the approval process, DiaMonTech will align with the FDA on the regulatory approval path for the US.

Stay tuned and get updates.

Notify Me